Oakworth Capital Inc. continued to hold its position in shares of Clorox Company (The) (NYSE:CLX) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 886 shares of the company’s stock at the end of the second quarter. Oakworth Capital Inc.’s holdings in Clorox Company (The) were worth $118,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the company. American Beacon Advisors Inc. purchased a new position in shares of Clorox Company (The) during the first quarter valued at about $104,000. Quadrant Capital Group LLC boosted its position in shares of Clorox Company (The) by 23.0% in the first quarter. Quadrant Capital Group LLC now owns 846 shares of the company’s stock valued at $106,000 after buying an additional 158 shares in the last quarter. Parkside Financial Bank & Trust boosted its position in shares of Clorox Company (The) by 3.8% in the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock valued at $107,000 after buying an additional 29 shares in the last quarter. Valley National Advisers Inc. boosted its position in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock valued at $116,000 after buying an additional 5 shares in the last quarter. Finally, Blue Chip Partners Inc. boosted its position in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after buying an additional 6 shares in the last quarter. 70.29% of the stock is owned by hedge funds and other institutional investors.

Shares of Clorox Company (NYSE CLX) opened at 134.31 on Friday. Clorox Company has a 12 month low of $111.24 and a 12 month high of $141.76. The stock has a 50 day moving average price of $133.58 and a 200-day moving average price of $133.56. The stock has a market cap of $17.34 billion, a P/E ratio of 25.18 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last released its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.04. The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The company’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.30 earnings per share. On average, analysts forecast that Clorox Company will post $5.67 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Oakworth Capital Inc. Has $118,000 Stake in Clorox Company (The) (NYSE:CLX)” was originally reported by Daily Political and is the sole property of of Daily Political. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://www.dailypolitical.com/2017/08/13/oakworth-capital-inc-has-118000-stake-in-clorox-company-the-nyseclx.html.

A number of research firms have recently weighed in on CLX. Jefferies Group LLC reissued a “hold” rating and issued a $137.00 price target (up from $136.00) on shares of Clorox Company (The) in a report on Wednesday. Royal Bank Of Canada reissued a “hold” rating and issued a $115.00 price target on shares of Clorox Company (The) in a report on Wednesday, August 2nd. Zacks Investment Research cut Clorox Company (The) from a “buy” rating to a “hold” rating in a report on Monday, July 31st. BidaskClub cut Clorox Company (The) from a “sell” rating to a “strong sell” rating in a report on Monday, July 24th. Finally, Barclays PLC reissued an “equal weight” rating and issued a $136.00 price target (down from $140.00) on shares of Clorox Company (The) in a report on Friday, August 4th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.